U.S. FDA Recalls Millions of Antidepressant Capsules Over Potential Cancer Risk
The U.S. Food and Drug Administration has initiated a voluntary recall of millions of duloxetine delayed-release capsules, a common antidepressant used by hundreds of thousands of Americans. Manufacturer Towa Pharmaceutical and its American distributor, Breckenridge Pharmaceutical, are withdrawing both 30mg and 60mg versions of the generic medication—marketed as a counterpart to the brand-name drug Cymbalta….